This is BrainsWay’s global website. The global website is not intended for persons in the United States and includes information on clinical indications that were not cleared by the FDA, which are subject to further US regulatory review for safety and efficacy. BrainsWay is cleared by the FDA only for patients with MDD who failed to respond to one or more anti-depressants in the current episode, and for patients with OCD as an adjunct treatment.
The provider network includes group practices, licensed independent clinicians and hospitals. The information contained in this network provider directory is submitted by providers. You may also get help finding a provider by calling our access line at 1-844-386-7001.